Extramedullary disease in multiple myeloma in the era of novel agents
- 30 March 2015
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 169 (6) , 763-765
Abstract
No abstract availableKeywords
Funding Information
- Instituto de Salud Carlos III (PI12/1093)
- Instituto de Salud Carlos III (RD12/0036/0046)
This publication has 14 references indexed in Scilit:
- State of the art imaging of multiple myeloma: Comparative review of FDG PET/CT imaging in various clinical settingsEuropean Journal of Radiology, 2014
- Extramedullary Myeloma Spread Triggered by Surgical Procedures: An Emerging Entity?Acta Haematologica, 2014
- Myeloma in Scar Tissue - An Underreported Phenomenon or an Emerging Entity in the Novel Agents' Era? A Single Center SeriesActa Haematologica, 2014
- Soft-tissue extramedullary multiple myeloma prognosis is significantly worse in comparison to bone-related extramedullary relapseHaematologica, 2013
- Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agentsHaematologica, 2012
- Soft-Tissue Plasmacytomas in Multiple Myeloma: Incidence, Mechanisms of Extramedullary Spread, and Treatment ApproachJournal of Clinical Oncology, 2011
- Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3Blood, 2011
- Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myelomaLeukemia, 2011
- Extensive soft‐tissue involvement by plasmablastic myeloma arising from displaced humeral fracturesEuropean Journal of Haematology, 2010
- Extravasation and homing mechanisms in multiple myelomaClinical & Experimental Metastasis, 2007